共 50 条
- [1] Can we afford to ignore missing data in cost-effectiveness analyses? The European Journal of Health Economics, 2009, 10 : 1 - 3
- [4] Budget impact and cost-effectiveness: can we afford precision medicine in oncology? SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2016, 76 : S6 - S11
- [5] Can Clinical Guidelines Afford to Ignore Cost Effectiveness? An Ethical Perspective PharmacoEconomics, 2016, 34 : 529 - 531
- [8] Can we afford the future: effectiveness or cost-effectiveness as the criterion for introducing new therapies for breast cancer? EJC SUPPLEMENTS, 2008, 6 (07): : 51 - 51
- [9] When Can We Ignore Missing Data in Model Training? PROCEEDINGS OF THE SEVENTH WORKSHOP ON DATA MANAGEMENT FOR END-TO-END MACHINE LEARNING, DEEM, 2023,